Kendra E Wulczyn, Tariq Shafi, Amanda Anderson, Hernan Rincon-Choles, Clary B Clish, Michelle Denburg, Harold I Feldman, Jiang He, Chi-Yuan Hsu, Tanika Kelly, Paul L Kimmel, Rupal Mehta, Robert G Nelson, Vasan Ramachandran, Ana Ricardo, Vallabh O Shah, Anand Srivastava, Dawei Xie, Eugene P Rhee, Sahir Kalim
RATIONALE & OBJECTIVE: The toxins contributing to uremic symptoms in patients with CKD are unknown. We sought to apply complementary statistical modeling approaches to data from untargeted plasma metabolomic profiling to identify solutes associated with uremic symptoms in patients with CKD. STUDY DESIGN: Cross-sectional. SETTING & PARTICIPANTS: 1,761 Chronic Renal Insufficiency Cohort (CRIC) participants with CKD not on dialysis. PREDICTORS: Measurement of 448 known plasma metabolites...
January 22, 2024: American Journal of Kidney Diseases